Tuberculosis incidence and treatment completion among Ugandan prison inmates

International Journal of Tuberculosis and Lung Disease

Volumn 18, Issue 7, 2014, Pages

  Schwitters, Amee ^a   Kaggwa, M ^b   Omiel, P ^c   Nagadya, G ^c   Kisa, N ^b   Dalal, S ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Uganda Prisons Service   (Uganda)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Prisons; TB; Uganda

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; COMORBIDITY; DISEASE SURVEILLANCE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRIORITY JOURNAL; PRISON; PRISONER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STRATEGIC PLANNING; TREATMENT OUTCOME; TREND STUDY; TUBERCULOSIS; UGANDA; YOUNG ADULT; ADOLESCENT; HIV INFECTIONS; INCIDENCE; MEDICATION COMPLIANCE; PREVALENCE; STATISTICS AND NUMERICAL DATA; TIME;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MEDICATION ADHERENCE; PREVALENCE; PRISONERS; PRISONS; RETROSPECTIVE STUDIES; TIME FACTORS; TUBERCULOSIS; UGANDA; YOUNG ADULT;

EID: 84903490064     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0934     Document Type: Article

References (36)

1. Kompala T, Shenoi S V, Friedland G. Transmission of tuberculosis in resource-limited settings. Curr HIV/AIDS Rep 2013; 10: 264-272.
2. Chaisson R E, Martinson N A. Tuberculosis in Africa - combating an HIV-driven crisis. N Engl J Med 2008; 358: 1089-1092. (Pubitemid 351398482)
3. Reid S E, Topp S M, Turnbull E R, et al. Tuberculosis and HIV control in sub-Saharan African prisons: 'thinking outside the prison cell'. J Infect Dis 2012; 205 (Suppl 2): S265-S273.
4. Nolan C M, Blumberg H M, Taylor Z, et al. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172: 1169-1227.
5. Baussano I, Williams B G, Nunn P, et al. Tuberculosis incidence in prisons: a systematic review. PLOS MED 2010; 7: e1000381.
6. Angie B, Ann A, Malgosia G, et al. Tuberculosis control in prisons: a manual for programme managers. Geneva, Switzerland: World Health Organization, 2000.
7. Dara M, Grzemska M, Kimerling M E, Reyes H, Zagorskiy A. Guidelines for control of tuberculosis in prisons. Washington DC, USA: The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), US Agency for International Development, 2009.
8. Todrys K W, Amon J J. Criminal justice reform as HIV and TB prevention in African prisons. PLOS MED 2012; 9: e1001215.
9. Johnstone-Robertston S, Lawn S D, Welte A, Bekker L G, Wood R. Tuberculosis in a South African prison - a transmission modeling analysis. S Afr Med J 2011; 101: 809-813.
10. United Nations Office on Drugs and Crime (UNODC). Report on the UNODC prisons assessment mission to Uganda. Persisting challenges and emerging strengths: findings and recommendations. Vienna, Austria: UNODC, 2009.
11. World Health Organization. Global tuberculosis report. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
12. Todrys K W, Amon J J, Malembeka G, Clayton M. Imprisoned and imperiled: Access to HIV and TB prevention and treatment and denial of human rights in Zambian prisons. J Intl AIDS Soc 2011; 14: 1-11.
13. O'Grady J, Hoelscher M, Atun R, et al. Tuberculosis in prisons in sub-Saharan Africa - the need for improved health services, surveillance, and control. Tuberculosis 2011; 91: 173-178.
14. Ferrari M J. Eleven million adults co-infected with AIDS, TB. Can Med Assoc J 2004; 171: 437.
15. Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective study. Lancet 2010; 375: 1798-1807.
16. United Nations Office on Drugs and Crime. HIVand prisons in sub-Saharan Africa: opportunities for action. Geneva, Switzerland: UNODC, 2007.
17. Habeenzu C, Mitarai S, Lubasi D, et al. Tuberculosis and multidrug resistance in Zambian prisons, 2000-2001. Int J Tuberc Lung Dis 2007; 11: 1216-1220. (Pubitemid 350146303)
18. Coninx R, Maher D, Reyes H, Grzemska M. Tuberculosis in prisons in countries with high prevalence. BMJ 2000; 12: 440-442. (Pubitemid 30175778)
19. O'Grady J, Mwaba P, Bates M, Kapata N, Zumla A. Tuberculosis in prisons in sub-Saharan Africa - a potential time bomb. S Afr Med J 2011; 101: 107-107.
20. Ministry of Health, Republic of Uganda. Manual of the National Tuberculosis and Leprosy Programme. 2nd ed. Kampala, Uganda: MoH, 2010.
21. World Health Organization. Treatment of tuberculosis guidelines. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2010.
22. Dara M, Chadha S S, Melchers N V, et al. Time to act to prevent and control tuberculosis among inmates. Int J Tuberc Lung Dis 2013; 17: 4-5.
23. Vinkeles-Melchers N V S, van Elsland S L, Lange J M A, Borgdorff M W, van den Hombergh J. State of affairs of tuberculosis in prison facilities: a systematic review of screening practices and recommendations for best TB control. PLOS ONE 2013; 8: e53644.
24. Winetsky D E, Negoescu DM, DeMarchis E H, et al. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effective analysis. PLOS MED 2012; 9: e1001348.
25. Beyene M, Amare B, Asfaw F, et al. Prevalence of smear-positive pulmonary tuberculosis among prisoners in North Gondar zone prison, northwest Ethiopia. BMC Infect Dis 2012; 12: 352.
26. Kyomya M, Todyrs K W, Amon J J. Laws against sodomy and the HIV epidemic in African prisons. Lancet 2012; 380: 310-312.
27. World Health Organization. Policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. WHO/HTM/TB/2012.1. WHO/HIV/2012.1. Geneva, Switzerland: WHO, 2012.
28. Becerra M C, Freeman J, Bayona J, et al. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2000; 4: 108-114. (Pubitemid 30123642)
29. Chiang C-Y, Hsu C J, Huang R M, Lin T P, Luh K T. Antituberculosis drug resistance among retreatment tuberculosis patients in a referral center in Taipei. J Formos Med Assoc 2004; 103: 411-415. (Pubitemid 39302895)
30. Zignol M, Hosseini M S, Wright A, et al. Global incidence of multidrug resistant tuberculosis. J Infect Dis 2006; 194: 479-485. (Pubitemid 44162659)
31. Hafkin J, Gammino VM, Amon J J. Drug-resistant tuberculosis in sub-Saharan Africa. Curr Infect Dis Rep 2010; 12: 36-45.
32. Lukoye D, Adatu F, Musisi K, et al. Anti-tuberculosis drug resistance among new and previously treated sputum smearpositive tuberculosis patients in Uganda: results of the first national survey. PLOS ONE 2013; 8: e70763.
33. Public Health England Health Protection Services Prison Network. Management of tuberculosis in prisons: guidance for prison healthcare teams. London, UK: Public Health England, 2013.
34. West D. How mobile devices are transforming healthcare. Issues in Technology Innovation 2012; 18: 1-14. http://www.insidepolitics.org/ brookingsreports/mobile-health-52212.pdf Accessed April 2014
35. Reyes H, Coninx R. Pitfalls of tuberculosis programmes in prisons. BMJ 1997; 315: 1447-1450. (Pubitemid 27510733)
36. Anderson C, Dara M, Hauer B, et al. Methodological issues in quantifying the magnitude of the tuberculosis problem in a prison population. Int J Tuberc Lung Dis 2011; 15: 662-667.